1. Any test for the human immunodeficiency virus, including, without limitation, a rapid test, that is used to carry out the provisions of NRS 442.600 to 442.660 , inclusive, must be approved by the United States Food and Drug Administration. 2. Each test administered to a woman or performed on a child pursuant to the provisions of NRS 442.600 to 442.660 , inclusive, must be administered or performed in accordance with: (a) The provisions of chapter 652 of NRS and any regulations adopted pursuant thereto; and (b) The Clinical Laboratory Improvement Amendments of 1988, Public Law No. 100-578, 42 U.S.C. 263a, if applicable.
‹ Prev All Nevada sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.